Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1490.3000 65.90 (4.63%)
NSE Oct 26, 2026 15:31 PM
Volume: 189.8K
 

logo
Rubicon Research Ltd.
13 Nov 2025
1490.30
4.63%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research Ltd. is trading below its 30 day SMA of 1611.5
More from Rubicon Research Ltd.
Recommended
Primary market awaits Jio Platforms' listing as nine new issues enter the pipeline
| 26 Oct 2026, 05:33PM
Market closes higher, led by IT and financial stocks
Trendlyne Marketwatch | 26 Oct 2026, 04:02PM
Pre Monday: An optimist surveys the market during earnings season
The Baseline | 24 Oct 2026